Biostar Pharmaceuticals, a Xianyang-based manufacturer of over-the-counter Hepatitis B medicine, has hired Zack Zibing Pan as its new chief financial officer (CFO). This appointment followed resignation of Deyin (Bill) Chen, for personal reasons. Prior to this appointment, Pan served as an independent member of the board and the chairman of the audit committee of the board of directors of the company and, consequently, had to step down as a board and audit committee member in order to be engaged as the company’s new CFO.
Pan has over 10 years of accounting and finance experience. Previously, he was CFO of China Education Alliance, where he was appointed in August 2009. Prior to that, Pan was an audit manager with Eide Bailly CPAs & Business Advisors, where he has been employed since September 2005.
From September 1998 to September 2005, Pan was a statistical analyst and economist with the State of Oklahoma. Pan graduated with a MBA from the University of Central Oklahoma in 1999. He holds a BA degree from Anhui University, China (1988). He is a certified public accountant (CPA), certified by the Oklahoma State Board of Accountancy, and member of American Institute of Certified Public Accountant and Oklahoma Society of Certified Public Accountants.
The annual BNP Paribas Cash Management University kicked off on Thursday morning with treasury professionals congregating in Paris from across Europe.
APIs may be a solution to MT940 challenges, says Karen Fagan, treasury operation manager, for British television company, ITV.
Kicking off the first day of the Singapore Fintech Festival, issues with cryptocurrencies were addressed by MIT media labs director, Joi Ito, and panels of technology leaders discussed how they’re using data analytics.
Sibos 2017 day two highlights: Brexit and banking, and why ‘data is the new oil’ in financial services
How nation first politics can impact global financial organisations It’s clear that data and regulation are the two key topics that are ... read more